Monoclonal Antibody Treatment Transfusion and Anti-CD154 with Combined Donor-Specific Optimally Induce Allograft Tolerance CTLA4 Signals Are Required to

References es http://www.jimmunol.org/cgi/content/full/162/8/4983#otherarticl38 online articles that cite this article can be accessed at: €http://www.jimmunol.org/cgi/content/full/162/8/4983#BIBL This article cites 31 articles, 13 of which can be accessed free at: Subscriptions online at http://www.jimmunol.org/subscriptions/ Information about subscribing to The Journal of Immunology isPermissions http://www.aai.org/ji/copyright.html Submit copyright permission requests at Email Alerts up at http://www.jimmunol.org/subscriptions/etoc.shtml Receive free email alerts when new articles cite this article. Sign

[1]  J Bajorath,et al.  Immune regulation by CD40 and its ligand GP39. , 1996, Annual review of immunology.

[2]  T. Strom,et al.  Increased CD40 ligand gene expression during human renal and murine islet allograft rejection. , 1998, Transplantation.

[3]  P. Linsley,et al.  The role of donor and recipient B7-1 (CD80) in allograft rejection. , 1997, Journal of immunology.

[4]  P. Linsley,et al.  Prolonged acceptance of concordant and discordant xenografts with combined CD40 and CD28 pathway blockade. , 1998, Transplantation.

[5]  P. Nickerson,et al.  Ex vivo coating of islet cell allografts with murine CTLA4/Fc promotes graft tolerance. , 1995, Journal of immunology.

[6]  J. Bluestone,et al.  CD28/B7 system of T cell costimulation. , 1996, Annual review of immunology.

[7]  L. Turka,et al.  The role of T-cell costimulatory activation pathways in transplant rejection. , 1998, The New England journal of medicine.

[8]  T. Strom,et al.  Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. , 1997, Immunity.

[9]  D. Harlan,et al.  CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[10]  A. Aruffo,et al.  CD40-gp39 interactions play a critical role during allograft rejection. Suppression of allograft rejection by blockade of the CD40-gp39 pathway. , 1996, Transplantation.

[11]  P. Linsley,et al.  Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. , 1992, Science.

[12]  T. Strom,et al.  Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[13]  T. Foy,et al.  The role of CD40 and its ligand (gp39) in peripheral and central tolerance and its contribution to autoimmune disease. , 1994, Research in immunology.

[14]  J. Bluestone,et al.  The B7 and CD28 receptor families. , 1994, Immunology today.

[15]  K. Wood,et al.  Transplantation tolerance induced by antigen pretreatment and depleting anti‐CD4 antibody depends on CD4+ T cell regulation during the induction phase of the response , 1995, European journal of immunology.

[16]  C. Thompson,et al.  Brief Definitive Report Cytotoxic T Lymphocyte Antigen 4 (CTLA4) Blockade Accelerates the Acute Rejection of Cardiac Allografts in CD28-deficient Mice: CTLA4 Can Function Independently of CD28 , 2022 .

[17]  M. Waer,et al.  Factors involved in rejection of concordant xenografts in complement-deficient rats. , 1997, Transplantation.

[18]  R. Noelle,et al.  Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4. , 1998, The Journal of clinical investigation.

[19]  J. Gribben,et al.  Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production , 1993, The Journal of experimental medicine.

[20]  R. Noelle,et al.  Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[21]  P. Linsley,et al.  CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2 , 1995, The Journal of experimental medicine.

[22]  P. Nickerson,et al.  CTLA4Ig attenuates accelerated rejection (presensitization) in the mouse islet allograft model. , 1997, Transplantation.

[23]  H. Griesser,et al.  Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4 , 1995, Science.

[24]  J. Gribben,et al.  Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[25]  P. Linsley,et al.  Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[26]  L. Turka,et al.  Donor antigen is necessary for the prevention of chronic rejection in CTLA4Ig-treated murine cardiac allograft recipients. , 1997, Transplantation.

[27]  J. Allison,et al.  CTLA-4 blockade synergizes with tumor-derived granulocyte-macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[28]  P. Terasaki,et al.  THE SIGNIFICANCE OF A POSITIVE FLOW CYTOMETRY CROSSHATCH TEST IN PRIMARY KIDNEY TRANSPLANTATION , 1993, Transplantation.

[29]  P. Linsley,et al.  CTLA-4 can function as a negative regulator of T cell activation. , 1994, Immunity.